SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
Level 8, 210 George Street, Sydney NSW 2000 GPO Box 3993 Sydney NSW 2001
Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)The company will hold its general meeting at Suite 2, Level 8, 66 Clarence Street, Sydney, NSW at 3pm (Sydney time) on 7 November 2025. | 08/10/2025 |
The company has reached an agreement to sell its businesses and assets to AXO Medtech VCC of Singapore, pending shareholder approval in November 2025. This decision comes after sustained financial losses and difficulties in securing funding in Australia. The sale involves Uscom's subsidiary, Uscom Sng Pte. Ltd, which is valued at $2.591 million and holds all of Uscom's intellectual property. Uscom will transfer existing liabilities, leading to approximately $200,000 in cash assets post-sale, and the agreement awaits regulatory approvals and standard transaction conditions. | 30/09/2025 |
ASX has suspended Uscom Limited's securities from quotation due to breach of Listing Rule 12.2, based on the company's financial condition and auditor's report. The suspension will continue until ASX determines compliance with the rules and if securities can be reinstated to quotation. | 29/09/2025 |
The suspension of trading in the securities of USCOM Ltd will be lifted immediately, following the release by UCM of an announcement regarding a clarification of a recent announcement of UCM's orders. | 11/02/2020 |
The company releases a clarification to market in response to a request for further information and suspension from the ASX. Uscom is planning to increase manufacturing output by approximately 121% on 10 year average outputs to meet the anticipated demand for H2. Unit orders for the first five weeks of 2020 are up 124% compared to the first full two months of 2019 from 17 to 38 (unaudited), and prior to the Government announcement. Uscom will continue to update the market with material information as it is confirmed and will release its 4C as required. | 11/02/2020 |
The securities of USCOM Ltd will be suspended from quotation immediately under Listing Rule 17.3, pending the release of an announcement regarding a clarification of a recent announcement of UCM's orders. | 10/02/2020 |
The suspension of trading in the securities of Uscom Limited (the "Company") will be lifted immediately, following receipt of an announcement regarding a capital raising and transaction. Security Code: UCM | 20/07/2015 |
The company s pleased to announce the completion of a $1.55m Placement to professional and sophisticated investors (Placement). The company is also pleased to announce a Share Purchase Plan (SPP) to be underwritten up to $400k by Patersons Securities Limited (Patersons). The proceeds from the capital raise will be used to fund the acquisition of Thor Laboratories KFT (Thor), integration of Thor's operations into Uscom's existing operations, and for working capital. | 20/07/2015 |
The company releases its July 2015 Investor Presentation. | 20/07/2015 |
The securities of Uscom Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising and transaction. Security Code: UCM | 17/07/2015 |
listed entity carried for record purposes only | 01/07/2004 |
DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
---|---|---|---|---|
29/06/2021 | Rob Phillips | 165,579 | $0.166 | $27,453.00 |
28/06/2021 | Rob Phillips | 644,627 | $0.159 | $102,293.00 |
26/05/2021 | Xianhui Meng | 422,292 | $0.178 | $75,081.00 |
25/05/2021 | Xianhui Meng | 1,000,000 | $0.145 | $144,643.00 |
09/12/2020 | Brett Crowley | 200,000 | $0.186 | $37,274.00 |
NAME | TITLE | DATE OF APPT |
---|---|---|
Rob Phillips | Chairman, CEO | 23/12/1999 |
Xianhui Meng | Non Exec Director | 16/12/2019 |
Christian Bernecker | Non Exec Director | 25/11/2011 |
Brett Crowley | Non Exec Director, Company Secretary | 23/08/2018 |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|
Date of first appointment, title may have changed.